Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 28840842)

  • 1. Chemokine and chemokine receptor patterns in patients with benign and malignant salivary gland tumors: a distinct role for CCR7.
    Haghshenas MR; Ashraf MJ; Khademi B; Ghaderi A; Erfani N; Razmkhah M
    Eur Cytokine Netw; 2017 Mar; 28(1):27-35. PubMed ID: 28840842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological Profile of Salivary Gland Tumors in Southern Iranian Population: A Retrospective Study of 405 Cases.
    Ghaderi H; Kruger E; Ahmadvand S; Mohammadi Y; Khademi B; Ghaderi A
    J Cancer Epidemiol; 2023; 2023():8844535. PubMed ID: 38026266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between CXCR4, CXCR5 and CCR7 expression and survival outcomes in patients with clinical T1N0M0 non-small cell lung cancer.
    Yue Z; Ningning D; Lin Y; Jianming Y; Hongtu Z; Ligong Y; Feng L; Shuaibo W; Yousheng M
    Thorac Cancer; 2020 Oct; 11(10):2955-2965. PubMed ID: 32896997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between chemokine/chemokine receptor and glioma prognosis and outcomes: Systematic review and meta-analysis.
    Yang S; Luo M; Yang S; Yuan M; Zeng H; Xia J; Wang N
    Int Immunopharmacol; 2024 May; 133():112047. PubMed ID: 38631221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential gene expression during capillary morphogenesis in a microcarrier-based three-dimensional in vitro model of angiogenesis with focus on chemokines and chemokine receptors.
    Sun XT; Zhang MY; Shu C; Li Q; Yan XG; Cheng N; Qiu YD; Ding YT
    World J Gastroenterol; 2005 Apr; 11(15):2283-90. PubMed ID: 15818740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor microenvironment of benign and malignant salivary gland tumors.
    Wai KC; Okholm TLH; Ha PK; Marquez DM; Tenvooren I; Jones KB; Spitzer MH
    Head Neck; 2024 Jul; 46(7):1625-1636. PubMed ID: 38454566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonography characteristics of cystic components in primary salivary gland tumors.
    Ding A; Lv H; Cao J; Wang X; Xiong P
    BMC Cancer; 2023 Sep; 23(1):833. PubMed ID: 37670285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression.
    Rizeq B; Malki MI
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32340161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-26a and miR-191 are upregulated while PLAG1 and HIF2 are downregulated in pleomorphic adenomas of the salivary glands compared to Warthin tumors.
    Carkic J; Nikolic N; Sango V; Riberti N; Anicic B; Milasin J
    J Oral Pathol Med; 2024 Jun; ():. PubMed ID: 38853518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges.
    Vela M; Aris M; Llorente M; Garcia-Sanz JA; Kremer L
    Front Immunol; 2015; 6():12. PubMed ID: 25688243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM).
    Du J; Lin Z; Fu XH; Gu XR; Lu G; Hou J
    Cell Commun Signal; 2024 Mar; 22(1):177. PubMed ID: 38475811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy.
    Takacs GP; Flores-Toro JA; Harrison JK
    Pharmacol Ther; 2021 Jun; 222():107790. PubMed ID: 33316289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-C motif chemokine receptors in gastric cancer.
    Ryu H; Baek SW; Moon JY; Jo IS; Kim N; Lee HJ
    Mol Clin Oncol; 2018 Jan; 8(1):3-8. PubMed ID: 29285394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4 Ligands: The Next Big Hit?
    Walenkamp AME; Lapa C; Herrmann K; Wester HJ
    J Nucl Med; 2017 Sep; 58(Suppl 2):77S-82S. PubMed ID: 28864616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Osteogenic and Chondrogenic Differentiation Ability of Buccal Fat Pad Derived Mesenchymal Stem Cells and Gingival Derived Cells.
    Ghaderi H; Razmkhah M; Kiany F; Chenari N; Haghshenas MR; Ghaderi A
    J Dent (Shiraz); 2018 Jun; 19(2):124-131. PubMed ID: 29854886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL12-CXCR4 Axis Is Required for Contact-Mediated Human B Lymphoid and Plasmacytoid Dendritic Cell Differentiation but Not T Lymphoid Generation.
    Minami H; Nagaharu K; Nakamori Y; Ohishi K; Shimojo N; Kageyama Y; Matsumoto T; Sugimoto Y; Tawara I; Masuya M; Miwa H; Katayama N
    J Immunol; 2017 Oct; 199(7):2343-2355. PubMed ID: 28842468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR7 Sulfotyrosine Enhances CCL21 Binding.
    Phillips AJ; Taleski D; Koplinski CA; Getschman AE; Moussouras NA; Richard AM; Peterson FC; Dwinell MB; Volkman BF; Payne RJ; Veldkamp CT
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinoma.
    Chen Z; Yang X; Bi G; Liang J; Hu Z; Zhao M; Li M; Lu T; Zheng Y; Sui Q; Yang Y; Zhan C; Jiang W; Wang Q; Tan L
    Int J Biol Sci; 2020; 16(12):2205-2219. PubMed ID: 32549766
    [No Abstract]   [Full Text] [Related]  

  • 19. Expressions of CXCL12, CXCL10 and CCL18 in Warthin tumors characterized pathologically by having a lymphoid stroma with germinal centers.
    Mochizuki K; Oishi N; Kawai M; Odate T; Tahara I; Inoue T; Kasai K; Kondo T
    Histol Histopathol; 2021 Sep; 36(9):931-938. PubMed ID: 34124768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines Explored in Saliva and Tears from Radiated Cancer Patients Correlate with Clinical Manifestations, Influencing Important Immunoregulatory Cellular Pathways.
    Aqrawi LA; Chen X; Hynne H; Amdal C; Reppe S; Aass HCD; Rykke M; Hove LH; Young A; Herlofson BB; Westgaard KL; Utheim TP; Galtung HK; Jensen JL
    Cells; 2020 Sep; 9(9):. PubMed ID: 32911805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.